Clinical Trial

Imaging of Brain Amyloid Plaques in the Aging Population

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
This is a prospective, open label, non-therapeutic, diagnostic imaging study. The purpose of this study is to utilize Pittsburgh Compound B positron emission imaging (PiB PET) to ascertain the relationship between change in amyloid burden over time, and concurrent change in clinical status.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2009-07-30; most recent amendment 2026-06-18.
Status change: Recruiting → Enrolling by Invitation 2009-09-16
Trial Details
NCT Number NCT00950430
Lead Sponsor Mayo Clinic
Collaborators: National Institute on Aging (NIA)
Conditions Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia, Vascular Dementia
Enrollment 8,000 participants
Start Date 2008-04
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-23